Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - IVAX Corporation (AMEX:IVX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
4400 Biscayne Boulevard
Miami, FL 33137
Phone: (305) 575-6000
Fax: (305) 575-6055
Email: ir@ivax.com
Employees (last reported count): 5,800
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 400 MidCap
Ownership
·Insider and 5%+ Owners: 29%
·Over the last 6 months:
 · 2 insider sells; 95.0K shares
  (0.2% of insider shares)
·Institutional: 62% (87% of float)
(581 institutions)
·Net Inst. Buying: 20.8M shares (+14.39%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
IVAX Corporation is a multinational company engaged in the research, manufacture and marketing of pharmaceutical products. Ivax manufactures and markets several brand name pharmaceutical products and a variety of generic and over-the-counter pharmaceutical products, primarily in the United States and the United Kingdom. The Company also has subsidiaries located throughout the world. In addition, IVAX holds approximately 470 United States and foreign patents and has several hundred United States and foreign patent applications pending.
More from Market Guide: Expanded Business Description

Financial Summary
IVAX Corp. is a holding company with subsidiaries engaged primarily in the R&D, manufacturing and marketing of branded and generic pharmaceuticals. For the six months ended 6/30/01, revenues rose 53% to $561.7 million. Net income before acctg. change and extraordinary item totalled $128 million, up from $59.1 million. Revenues reflect increased volume and new products in the North American region. Net income reflects a $10.3 million gain on the sale of a partial interest in IVAX Diagnostics.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Phillip Frost, M.D., 64
Chairman and CEO
$1.4M
Neil Flanzraich, 57
Vice Chairman and Pres
1.1M
Isaac Kaye, 71
Deputy CEO
1.2M
Thomas Beier, 55
Sr. VP- Fin. and CFO
--  
Steven Rubin
Sr. VP, Gen. Counsel, Sec.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:IVXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$21.192
Recent Price$33.66 
52-Week High
on 20-July-2001
$41.87 
Beta0.40 
Daily Volume (3-month avg)1.30M
Daily Volume (10-day avg)758.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+19.8%
52-Week Change
relative to S&P500
+60.7%
Share-Related Items
Market Capitalization$6.75B
Shares Outstanding200.6M
Float142.4M
Dividends & Splits
Annual Dividendnone 
Last Split: 5 for 4 on 21-May-2001
Per-Share Data
Book Value (mrq)$3.63 
Earnings (ttm)$1.01 
Earnings (mrq)$0.33 
Sales (ttm)$4.78 
Cash (mrq)$4.60 
Valuation Ratios
Price/Book (mrq)9.28 
Price/Earnings (ttm)33.33 
Price/Sales (ttm)7.05 
Income Statements
Sales (ttm)$987.0M
EBITDA (ttm)$224.7M
Income available to common (ttm)$208.6M
Profitability
Profit Margin (ttm)21.2%
Operating Margin (ttm)21.4%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)16.75%
Return on Equity (ttm)37.56%
Financial Strength
Current Ratio (mrq)5.43 
Debt/Equity (mrq)1.38 
Total Cash (mrq)$921.1M
Short Interest
As of 8-Aug-2001
Shares Short11.7M
Percent of Float8.2%
Shares Short
(Prior Month)
0 
Short Ratio6.95 
Daily Volume1.69M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.